Welcome
Support Centre
30 July 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Evaluation of an education and activation programme to prevent chronic shoulder complaints: design of a randomised clinical trial
ISRCTN ISRCTN71777817
ClinicalTrials.gov identifier
Public title Evaluation of an education and activation programme to prevent chronic shoulder complaints: design of a randomised clinical trial
Scientific title
Acronym N/A
Serial number at source 904-65-901
Study hypothesis An education and activation programme in addition to usual care is more effective in increasing patient perceived recovery and reducing functional limitations than usual care alone.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment The Netherlands
Disease/condition/study domain Shoulder complaints
Participants - inclusion criteria 1. Patient with shoulder complaint at rest and/or elicited by movement
2. 18 years and older
3. New episode of shoulder complaints
Participants - exclusion criteria 1. Other episodes of shoulder complaints in previous 12 months
2. Prior fractures and/or surgery of the shoulder
3. (Suspected) referred pain from internal organs
4. Confirmed extrinsic cause
5. Inability to complete a questionnaire independently
6. Presence of dementia or other severe psychiatric abnormalities
Anticipated start date 01/01/2000
Anticipated end date 31/12/2004
Status of trial Completed
Patient information material
Target number of participants 111
Interventions Usual care:
Usual care was applied according to the Dutch College of General Practitioners (DCGP) guidelines for shoulder complaints (version 1999). Management during the first two weeks consists of a wait-and-see policy with information and advice about shoulder complaints, possibly supplemented with analgesics or nonsteroidal anti-inflammatory drugs. If this approach has little or no effect, up to three corticosteroid injections can be given. Physiotherapy is considered for complaints persisting after six weeks or more. If the shoulder complaints persist, referral to a hospital-based specialist may be considered.

Education and activation programme in addition to usual care:
The focus of the Education and activation programme was to maintain or induce the proper cognitions by education and to stimulate adequate behaviour by means of advice on activities of daily living using principles of operant conditioning. The Education and activation programme consisted of a minimum of two sessions and a maximum of six follow-up sessions over a period of six weeks. Each session could last up to 20 minutes.
Primary outcome measure(s) Patient perceived recovery after six and 26 weeks.
Secondary outcome measure(s) Change in functional limitations of activities of daily living after six and 26 weeks.
Sources of funding The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Trial website
Publications 2005 Study protocol on http://www.ncbi.nlm.nih.gov/pubmed/15715914
Contact name Mr  Camiel Peter Carol  De Bruijn
  Address Mercuriusstraat 27
  City/town Brunssum
  Zip/Postcode 6446 RM
  Country Netherlands
  Tel +31 (0)6 23588088
  Fax +31 (0)45 5214547
  Email camieldebruijn@hetnet.nl
Sponsor The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
  Address Laan van Nieuw Oost Indië 334
P.O. Box 93245
  City/town The Hague
  Zip/Postcode 2509 AE
  Country Netherlands
  Tel +31 (0)70 349 5111
  Fax +31 (0)70 349 5100
  Email info@zonmw.nl
  Sponsor website: http://www.zonmw.nl/
Date applied 14/02/2005
Last edited 10/03/2008
Date ISRCTN assigned 14/02/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central